Is Corona Remedies Ltd debt-free?

No, Corona Remedies Ltd is not debt-free with a debt-to-equity ratio of .

Home

Corona Remedies Ltd

Corona Remedies Ltd Financials

Corona Remedies Ltd Financial Statement

Corona Remedies Ltd Income Statement

Quarterly

Annual

*All values are in Rs. Cr

No Data Available

Corona Remedies Ltd Profit & Loss

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Total Revenue Annual	1,196.42	1,014.47	884.05
Operating Expenses Annual	956.44	859.74	756.07
Operating Profit Annual	245.91	161.19	135.03
Interest Annual	10.60	14.44	4.27
Depreciation	15.39	12.97	11.03
Net Profit Annual	149.05	90.50	84.70
Tax Annual	49.10	27.98	25.96

Particulars	Mar 2025
Total Revenue Annual	1,196.42
Operating Expenses Annual	956.44
Operating Profit Annual	245.91
Interest Annual	10.60
Depreciation	15.39
Net Profit Annual	149.05
Tax Annual	49.10

Corona Remedies Ltd Cash Flow

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Cash Flow at the Beginning	3.16	14.49	6.82
Cash Flow from Operations	190.49	156.76	102.70
Cash Flow from Investing	-83.84	-266.64	-50.28
Cash Flow from Financing	-106.59	98.54	-44.75
Cash Flow at the End	3.22	3.16	14.49

Particulars	Mar 2025
Cash Flow at the Beginning	3.16
Cash Flow from Operations	190.49
Cash Flow from Investing	-83.84
Cash Flow from Financing	-106.59
Cash Flow at the End	3.22

Corona Remedies Ltd Key Ratios

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
PBDIT Margin (%)	20.55	15.89	15.27
PBIT Margin (%)	17.45	13.10	13
PBT Margin (%)	15.80	12.19	9.95
Net PROFIT Margin (%)	12.46	8.92	9.58
Return On Networth / Equity (%)	27.45	20.38	23.24
Return On Networth /Employed (%)	29.78	23.47	27.29
Return On Assets (%)	21.30	15.97	20.12
Total Debt / Equity (X)	0.23	0.21	0.08
Asset Turnover Ratio (%)	1.71	1.79	2.10

Particulars	Mar 2025
PBDIT Margin (%)	20.55
PBIT Margin (%)	17.45
PBT Margin (%)	15.80
Net PROFIT Margin (%)	12.46
Return On Networth / Equity (%)	27.45
Return On Networth /Employed (%)	29.78
Return On Assets (%)	21.30
Total Debt / Equity (X)	0.23
Asset Turnover Ratio (%)	1.71

Corona Remedies Ltd Balance Sheet

*All values are in Rs. Cr

Standalone

Consolidated

Particulars	Mar 2025	Mar 2024	Mar 2023
Fixed Assets Annual	369.88	383.70	184.60
Total Current Assets Annual	338.87	289.92	291.49
Non Current Assets Annual	590.37	540.42	303.31
Total Shareholders Funds Annual	605.73	480.18	408.29
Total Assets Annual	929.24	830.34	594.80

Particulars	Mar 2025
Fixed Assets Annual	369.88
Total Current Assets Annual	338.87
Non Current Assets Annual	590.37
Total Shareholders Funds Annual	605.73
Total Assets Annual	929.24

Corona Remedies Ltd Earning Calls

EPS (INR)

Expected

7.55

Reported

7.55

Surprise

0.00%

Dividend Pages

PE Ratio

FAQS on Corona Remedies Ltd Financials

As of Dec 15, 2025, Corona Remedies Ltd has a market capitalization of - Cr. Value Research classifies it as a Mega-Cap company.

Yes, Corona Remedies Ltd is not with a debt-to-equity ratio of .

In FY 2024 , Corona Remedies Ltd recorded a total revenue of approximately - Cr marking a significant milestone in the company's financial performance.

Corona Remedies Ltd's Future outlook anticipates robust growth, with forecasted earnings and revenue rising annually..

Corona Remedies Ltd's current PE ratio is .

Corona Remedies Ltd's ROCE averaged NaN% from the FY ending March NaN to NaN, with a median of NaN%. It peaked at -Infinity% in March NaN, reflecting strong capital efficiency over the period..

Corona Remedies Ltd's latest EBIT is Rs. - Cr, surpassing the average EBIT of Rs. - Cr over the 5 years..